Crinetics Pharmaceuticals Inc
NASDAQ:CRNX

Watchlist Manager
Crinetics Pharmaceuticals Inc Logo
Crinetics Pharmaceuticals Inc
NASDAQ:CRNX
Watchlist
Price: 58.78 USD -2.05% Market Closed
Market Cap: 5.3B USD
Have any thoughts about
Crinetics Pharmaceuticals Inc?
Write Note

Crinetics Pharmaceuticals Inc
Accumulated Depreciation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Crinetics Pharmaceuticals Inc
Accumulated Depreciation Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Accumulated Depreciation Analysis
Latest Figures & CAGR of Competitors

Company Accumulated Depreciation CAGR 3Y CAGR 5Y CAGR 10Y
Crinetics Pharmaceuticals Inc
NASDAQ:CRNX
Accumulated Depreciation
-$6.2m
CAGR 3-Years
-28%
CAGR 5-Years
-39%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Accumulated Depreciation
-$7.1B
CAGR 3-Years
-8%
CAGR 5-Years
-5%
CAGR 10-Years
-4%
Gilead Sciences Inc
NASDAQ:GILD
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Crinetics Pharmaceuticals Inc's Accumulated Depreciation?
Accumulated Depreciation
-6.2m USD

Based on the financial report for Jun 30, 2024, Crinetics Pharmaceuticals Inc's Accumulated Depreciation amounts to -6.2m USD.

What is Crinetics Pharmaceuticals Inc's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 5Y
-39%

Over the last year, the Accumulated Depreciation growth was -35%. The average annual Accumulated Depreciation growth rates for Crinetics Pharmaceuticals Inc have been -28% over the past three years , -39% over the past five years .

Back to Top